Abstract
Contrast-enhanced ultrasound (CEUS) is a specialized form of ultrasound (US) performed with an intravenous injection of microbubble contrast agents. It has been successfully used for a variety of applications including characterization of liver tumors. In April 2014, the American College of Radiology (ACR) convened a working group of international experts to develop ACR CEUS Liver Imaging Reporting and Data System (CEUS LI-RADS). An initial version of CEUS LI-RADS was published in August 2016. Although the CEUS LI-RADS concept and principles for liver lesion characterization, using dynamic contrast enhancement features, are similar to those for CT or MRI, there are significant differences between CT/MRI and CEUS LI-RADS. Therefore, CEUS LI-RADS has different diagnostic features and a unique characterization algorithm. The size of a lesion, the type and degree of arterial phase enhancement, the presence of washout, and the timing and degree of washout are the major features used for categorization. This paper describes key differences between CT/MRI and CEUS, and provides a diagnostic algorithm of CEUS LI-RADS with detailed, step-by-step instructions and imaging examples of CEUS LI-RADS categories.
Similar content being viewed by others
Abbreviations
- CEUS:
-
Contrast-enhanced ultrasound
- HCC:
-
Hepatocellular carcinoma
- LI-RADS:
-
Liver Imaging Reporting and Data System
- ICC:
-
Intrahepatic cholangiocarcinoma
- ACR:
-
American College of Radiology
- AASLD:
-
American Association for the Study of Liver Disease
- APHE:
-
Arterial phase hyperenhancement
- APS:
-
Arterioportal shunts
- TIV:
-
Tumor in vein
- MDD:
-
Multi-Disciplinary Discussion
References
Wilson SR, Jang HJ, Kim TK, Burns PN (2007) Diagnosis of focal liver masses on ultrasonography: comparison of unenhanced and contrast-enhanced scans. J Ultrasound Med 26(6):775–787
Jang HJ, Kim TK, Wilson SR (2009) Small nodules (1-2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound. Eur J Radiol 72(3):418–424. doi:10.1016/j.ejrad.2008.08.011
Strobel D, Seitz K, Blank W, et al. (2009) Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS). Ultraschall Med 30(4):376–382. doi:10.1055/s-0028-1109672
Niu Y, Huang T, Lian F, Li F (2013) Contrast-enhanced ultrasonography for the diagnosis of small hepatocellular carcinoma: a meta-analysis and meta-regression analysis. Tumour Biol 34(6):3667–3674. doi:10.1007/s13277-013-0948-z
Hanna RF, Miloushev VZ, Tang A, et al. (2016) Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma. Abdom Radiol 41(1):71–90 ((NY)). doi:10.1007/s00261-015-0592-8
Chou R, Cuevas C, Fu R, et al. (2015) Imaging techniques for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Ann Intern Med 162(10):697–711. doi:10.7326/M14-2509
Guang Y, Xie L, Ding H, Cai A, Huang Y (2011) Diagnosis value of focal liver lesions with SonoVue(R)-enhanced ultrasound compared with contrast-enhanced computed tomography and contrast-enhanced MRI: a meta-analysis. J Cancer Res Clin Oncol 137(11):1595–1605. doi:10.1007/s00432-011-1035-8
Xie L, Guang Y, Ding H, Cai A, Huang Y (2011) Diagnostic value of contrast-enhanced ultrasound, computed tomography and magnetic resonance imaging for focal liver lesions: a meta-analysis. Ultrasound Med Biol 37(6):854–861. doi:10.1016/j.ultrasmedbio.2011.03.006
Vilana R, Forner A, Bianchi L, et al. (2010) Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology 51(6):2020–2029. doi:10.1002/hep.23600
Li R, Yuan MX, Ma KS, et al. (2014) Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis. PLoS One 9(5):e98612. doi:10.1371/journal.pone.0098612
Wildner D, Bernatik T, Greis C, et al. (2015) CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients—early or late washout matters: a subanalysis of the DEGUM multicenter trial. Ultraschall Med 36(2):132–139. doi:10.1055/s-0034-1399147
Kono Y, Cosgrove D, Dietrich C, Jang HJ, Kim TK, Lyshchik A, Piscaglia F, Sirlin C, Willmann JK, Wilson S (2016) Contrast-enhanced ultrasound liver imaging reporting and data system for diagnosis of hepatocellular carcinoma: initial proposal. In: American Institute of Ultrasound in Medicine, New York. 16 Mar 2016–21 Mar 2016 2016. vol suppl. p S132
Jang HJ, Kono Y, Sirlin C, et al. (2015) Incorporation of CEUS into LI-RADS for diagnosis of hepatocellular carcinoma (HCC): a work in progress. In: Radiological Society of North America, Chicago, 29 Nov 2015–4 Dec 2015
Piscaglia F (2016) The new American CEUS LI-RADS classification of focal lesions in cirrhosis. In: Euroson Congress of the EFSUMB, Leipsig, Germany, 26–29 Oct 2016
Wilson SR, Kim TK, Jang HJ, Burns PN (2007) Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI. AJR Am J Roentgenol 189(1):W7–W12. doi:10.2214/AJR.06.1060
Claudon M, Dietrich CF, Choi BI, et al. (2013) Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver—update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 39(2):187–210. doi:10.1016/j.ultrasmedbio.2012.09.002
Terzi E, De Bonis L, Leoni S, et al. (2017) CEUS LI-RADS are effective in predicting the risk hepatocellular carcinoma of liver nodules. Dig Liver Dis 49(Suppl 1):e22
Choi J-Y, Cho HC, Sun M, Kim HC, Sirlin CB (2013) Indeterminate observations (liver imaging reporting and data system category 3) on MRI in the cirrhotic liver: fate and clinical implications. AJR Am J Roentgenol 201(5):993–1001
Tanabe M, Kanki A, Wolfson T, et al. (2016) Imaging outcomes of liver imaging reporting and data system version 2014 category 2, 3, and 4 observations detected at CT and MR imaging. Radiology 281(1):129–139
Galia M, Taibbi A, Marin D, et al. (2014) Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma? Diagn Interv Radiol 20(3):222–228. doi:10.5152/dir.2014.13184
Kono Y, Cosgrove D, Dietrich CF, Jang HJ, Kim TK, Lyshchik A, Piscaglia F, Sirlin CB, Vezeridis A, Willmann JK, Wilson SR (2016) Metaanalysis of diagnostic performance of CEUS LI-RADS® criteria for diagnosis of ≤ 2 cm hepatocellular carcinoma. In: AASLD Annual Meeting 2016, Boston
Jo PC, Jang HJ, Burns PN, et al. (2017) Integration of contrast-enhanced US into a multimodality approach to imaging of nodules in a cirrhotic liver: how i do it. Radiology 282(2):317–331
Acknowledgement
Images are from the University of Calgary using the contrast agent Definity (Lantheus Medical Imaging, Billerica MA).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wilson, S.R., Lyshchik, A., Piscaglia, F. et al. CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI. Abdom Radiol 43, 127–142 (2018). https://doi.org/10.1007/s00261-017-1250-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-017-1250-0